Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nonafact Post-Marketing Study in Hemophilia B
NCT00139828Phase 4Completed
- Sponsor
- Prothya Biosolutions
- Start
- May 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of human coagulation factor IX in hemophilia B (HB), sponsored by Prothya Biosolutions. Started May 2003; status: completed.
02
Drugs
human coagulation factor IX
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on NCT00139828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139828.